arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 10/2022 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    THERAPY FROM A CRITICAL VIEWPOINT

    GRADE study: long-term comparison of four antidiabetics

    NEW ON THE MARKET

    Eptinezumab (VYEPTY): forth antibody for prevention of migraine

    APEXXNAR and VAXNEUVANCE: new pneumococcal conjugate vaccines

    a-t READERS QUESTIONS AND COMMENTS

    New data on vitamin C against cancer?

    BEWARE MISINFORMATION

    VIRX (other trade names: ENOVID and FABISPRAY): nasal spray against COVID-19?
    free

    IN BRIEF

    Methylphenidate (RITALIN, generics): pitfalls to consider when switching preparations

    New sitagliptin generics – is the combination with extended-release metformin reasonable?

    ERRATUM

    Correction regarding bivalent COVID-19 mRNA vaccines

    SIDE EFFECTS

    Caution: topiramate (TOPAMAX, generics) during pregnancy

    e a-t ON THE INTERNET

    COVID-19: new data on molnupiravir (LAGEVRIO)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!